In the past decade a new class of drugs, the selective serotonin reuptake inhibitors (SSRIs), has become available for the treatment of patients with depressive illness. Four SSRIs, fluoxetine (Prozac – Dista), fluvoxamine (Faverin – Duphar), paroxetine (Seroxat – Smithkline Beecham) and sertraline (Lustral – Invicta/Pfizer), are marketed in the UK. How do they compare with the older and cheaper tricyclics?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.